The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
Comments Off on The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
March 5, 2026
Cannabinoid research barriers in the U.S. create challenges for developing evidence-based cannabis medicines. Federal scheduling under the Controlled Substances Act fragments the regulatory environment. This limits patient access to clinically validated…
Cannabis Industry Wage Crisis: Minimum Wage Catching Up to Once-Premium Jobs
Comments Off on Cannabis Industry Wage Crisis: Minimum Wage Catching Up to Once-Premium Jobs
February 23, 2026
The cannabis industry wage crisis is intensifying as minimum wages rise in 22 states and many cities in 2026. Budtender roles require specialized knowledge, but wages are no longer keeping pace. This shift pressures cannabis companies to consider…
5 Transformative Effects of Cannabis Rescheduling: Medical Insight
Comments Off on 5 Transformative Effects of Cannabis Rescheduling: Medical Insight
May 2, 2024
In a recent landmark announcement on Cannabis Rescheduling, President Biden expressed his administration's commitment to support the rescheduling of cannabis from Schedule 1 to Schedule 3 of the Controlled Substances Act. This shift could…